Revvity Quick Ratio 2012-2026 | RVTY
Historical quick ratio values for Revvity (RVTY) over the last 10 years.
| Revvity Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2026-06-30 | $1.92B | $1.28B | 1.50 |
| 2026-03-31 | $1.74B | $1.24B | 1.41 |
| 2025-12-31 | $1.86B | $1.33B | 1.40 |
| 2025-09-30 | $1.76B | $1.22B | 1.44 |
| 2025-06-30 | $1.85B | $0.67B | 2.75 |
| 2025-03-31 | $1.94B | $0.65B | 2.99 |
| 2024-12-31 | $1.98B | $0.65B | 3.04 |
| 2024-09-30 | $2.04B | $0.69B | 2.97 |
| 2024-06-30 | $2.76B | $1.39B | 1.98 |
| 2024-03-31 | $2.65B | $1.37B | 1.93 |
| 2023-12-31 | $2.57B | $1.45B | 1.77 |
| 2023-09-30 | $2.48B | $1.45B | 1.71 |
| 2023-06-30 | $3.09B | $1.37B | 2.26 |
| 2023-03-31 | $3.37B | $1.56B | 2.15 |
| 2022-12-31 | $2.88B | $1.54B | 1.87 |
| 2022-09-30 | $2.74B | $1.49B | 1.84 |
| 2022-06-30 | $1.48B | $1.04B | 1.42 |
| 2022-03-31 | $1.81B | $1.26B | 1.43 |
| 2021-12-31 | $2.02B | $1.21B | 1.66 |
| 2021-09-30 | $1.61B | $1.15B | 1.40 |
| 2021-06-30 | $1.75B | $1.12B | 1.56 |
| 2021-03-31 | $2.15B | $1.52B | 1.41 |
| 2020-12-31 | $1.72B | $1.65B | 1.04 |
| 2020-09-30 | $1.19B | $1.25B | 0.96 |
| 2020-06-30 | $1.05B | $1.16B | 0.91 |
| 2020-03-31 | $0.95B | $0.73B | 1.30 |
| 2019-12-31 | $1.02B | $0.76B | 1.33 |
| 2019-09-30 | $1.16B | $1.19B | 0.97 |
| 2019-06-30 | $0.92B | $0.71B | 1.31 |
| 2019-03-31 | $0.87B | $0.74B | 1.17 |
| 2018-12-31 | $0.90B | $0.77B | 1.16 |
| 2018-09-30 | $0.81B | $0.69B | 1.18 |
| 2018-06-30 | $0.84B | $0.71B | 1.17 |
| 2018-03-31 | $0.86B | $0.93B | 0.93 |
| 2017-12-31 | $0.85B | $0.95B | 0.89 |
| 2017-09-30 | $1.25B | $0.60B | 2.09 |
| 2017-06-30 | $1.16B | $0.59B | 1.97 |
| 2017-03-31 | $0.85B | $0.60B | 1.42 |
| 2016-12-31 | $0.94B | $0.60B | 1.56 |
| 2016-09-30 | $0.85B | $0.55B | 1.55 |
| 2016-06-30 | $0.78B | $0.56B | 1.39 |
| 2016-03-31 | $0.74B | $0.56B | 1.33 |
| 2015-12-31 | $0.77B | $0.56B | 1.38 |
| 2015-09-30 | $0.76B | $0.55B | 1.37 |
| 2015-06-30 | $0.77B | $0.57B | 1.33 |
| 2015-03-31 | $0.73B | $0.55B | 1.33 |
| 2014-12-31 | $0.78B | $0.60B | 1.31 |
| 2014-09-30 | $0.79B | $0.57B | 1.40 |
| 2014-06-30 | $0.80B | $0.58B | 1.39 |
| 2014-03-31 | $0.82B | $0.61B | 1.35 |
| 2013-12-31 | $0.78B | $0.60B | 1.30 |
| 2013-09-30 | $0.67B | $0.59B | 1.14 |
| 2013-06-30 | $0.65B | $0.56B | 1.15 |
| 2013-03-31 | $0.64B | $0.57B | 1.11 |
| 2012-12-31 | $0.72B | $0.58B | 1.25 |
| 2012-09-30 | $0.68B | $0.58B | 1.17 |
| 2012-06-30 | $0.65B | $0.59B | 1.11 |
| 2012-03-31 | $0.66B | $0.60B | 1.09 |
| 2011-12-31 | $0.64B | $0.60B | 1.07 |
| 2011-09-30 | $0.70B | $0.88B | 0.80 |
| 2011-06-30 | $0.85B | $0.56B | 1.53 |
| 2011-03-31 | $0.86B | $0.51B | 1.69 |
| 2010-12-31 | $0.88B | $0.52B | 1.70 |
| 2010-09-30 | $0.77B | $0.51B | 1.49 |
| 2010-06-30 | $0.69B | $0.51B | 1.35 |
| 2010-03-31 | $0.66B | $0.50B | 1.33 |
| 2009-12-31 | $0.71B | $0.50B | 1.42 |
| 2009-09-30 | $0.63B | $0.51B | 1.22 |
| 2009-06-30 | $0.60B | $0.50B | 1.22 |
| 2009-03-31 | $0.58B | $0.47B | 1.23 |
| 2008-12-31 | $0.63B | $0.52B | 1.22 |
| 2008-09-30 | $0.65B | $0.52B | 1.24 |
| 2008-06-30 | $0.66B | $0.57B | 1.16 |
| 2008-03-31 | $0.65B | $0.56B | 1.17 |
| 2007-12-31 | $0.65B | $0.55B | 1.19 |
| 2007-09-30 | $0.54B | $0.45B | 1.22 |
| 2007-06-30 | $0.51B | $0.45B | 1.13 |
| 2007-03-31 | $0.47B | $0.42B | 1.12 |
| 2006-12-31 | $0.56B | $0.48B | 1.18 |
| 2006-09-30 | $0.53B | $0.43B | 1.24 |
| 2006-06-30 | $0.64B | $0.42B | 1.52 |
| 2006-03-31 | $0.63B | $0.40B | 1.57 |
| 2005-12-31 | $0.84B | $0.50B | 1.69 |
| 2005-09-30 | $0.54B | $0.44B | 1.22 |
| 2005-06-30 | $0.50B | $0.47B | 1.07 |
| 2005-03-31 | $0.54B | $0.43B | 1.25 |
| 2004-12-31 | $0.58B | $0.45B | 1.30 |
| 2004-09-30 | $0.59B | $0.44B | 1.33 |
| 2004-06-30 | $0.57B | $0.44B | 1.29 |
| 2004-03-31 | $0.55B | $0.45B | 1.23 |
| 2003-12-31 | $0.58B | $0.45B | 1.28 |
| 2003-09-30 | $0.57B | $0.45B | 1.28 |
| 2003-06-30 | $0.74B | $0.62B | 1.19 |
| 2003-03-31 | $0.72B | $0.63B | 1.15 |
| 2002-12-31 | $0.78B | $0.68B | 1.14 |
| 2002-09-30 | $0.57B | $0.67B | 0.85 |
| 2002-06-30 | $0.66B | $0.60B | 1.09 |
| 2002-03-31 | $0.79B | $0.72B | 1.11 |
| 2001-12-31 | $0.70B | $0.76B | 0.93 |
| 2001-09-30 | $0.79B | $0.63B | 1.25 |
| 2001-06-30 | $0.72B | $0.68B | 1.06 |
| 2001-03-31 | $0.70B | $0.73B | 0.97 |
| 2000-12-31 | $0.74B | $0.65B | 1.14 |
| 2000-09-30 | $0.65B | $0.80B | 0.81 |
| 2000-06-30 | $0.59B | $0.81B | 0.74 |
| 2000-03-31 | $0.60B | $0.78B | 0.76 |
| 1999-12-31 | $0.61B | $0.85B | 0.72 |
| 1999-09-30 | $0.54B | $0.85B | 0.64 |
| 1999-06-30 | $0.52B | $0.97B | 0.54 |
| 1999-03-31 | $0.44B | $0.53B | 0.84 |
| 1998-12-31 | $0.44B | $0.52B | 0.83 |
| 1998-09-30 | $0.46B | $0.33B | 1.38 |
| 1998-06-30 | $0.46B | $0.32B | 1.45 |
| 1998-03-31 | $0.41B | $0.30B | 1.39 |
| 1997-12-31 | $0.38B | $0.29B | 1.31 |
| 1997-09-30 | $0.35B | $0.28B | 1.26 |
| 1997-06-30 | $0.35B | $0.30B | 1.16 |
| 1997-03-31 | $0.32B | $0.26B | 1.24 |
| 1996-12-31 | $0.34B | $0.26B | 1.29 |
| 1996-09-30 | $0.35B | $0.27B | 1.29 |
| 1996-06-30 | $0.36B | $0.29B | 1.25 |
| 1996-03-31 | $0.36B | $0.28B | 1.30 |
| 1995-12-31 | $0.35B | $0.25B | 1.42 |
| 1995-09-30 | $0.33B | $0.36B | 0.93 |
| 1995-06-30 | $0.33B | $0.28B | 1.18 |
| 1995-03-31 | $0.36B | $0.30B | 1.18 |
| 1994-12-31 | $0.36B | $0.28B | 1.27 |
| 1994-09-30 | $0.34B | $0.28B | 1.22 |
| 1994-06-30 | $0.33B | $0.25B | 1.36 |
| 1994-03-31 | $0.33B | $0.25B | 1.33 |
| 1993-12-31 | $0.34B | $0.24B | 1.45 |
| 1993-09-30 | $0.35B | $0.25B | 1.39 |
| 1993-06-30 | $0.37B | $0.28B | 1.32 |
| 1993-03-31 | $0.36B | $0.24B | 1.52 |
| 1992-12-31 | $0.37B | $0.24B | 1.57 |
| 1992-09-30 | $0.34B | $0.25B | 1.36 |
| 1992-06-30 | $0.34B | $0.27B | 1.26 |
| 1992-03-31 | $0.37B | $0.26B | 1.41 |
| 1991-12-31 | $0.34B | $0.24B | 1.41 |
| 1991-09-30 | $0.32B | $0.25B | 1.26 |
| 1991-06-30 | $0.31B | $0.26B | 1.20 |
| 1991-03-31 | $0.31B | $0.27B | 1.16 |
| 1990-12-31 | $0.29B | $0.26B | 1.14 |
| 1990-09-30 | $0.30B | $0.27B | 1.12 |
| 1990-06-30 | $0.29B | $0.25B | 1.19 |
| 1990-03-31 | $0.29B | $0.24B | 1.19 |
| 1989-12-31 | $0.29B | $0.26B | 1.13 |
| 1989-09-30 | $0.28B | $0.21B | 1.34 |
| 1989-06-30 | $0.27B | $0.20B | 1.36 |
| 1989-03-31 | $0.28B | $0.20B | 1.39 |
| 1988-12-31 | $0.26B | $0.17B | 1.52 |
| 1988-09-30 | $0.22B | $0.18B | 1.26 |
| 1988-06-30 | $0.22B | $0.20B | 1.09 |
| 1988-03-31 | $0.23B | $0.20B | 1.15 |
| 1987-12-31 | $0.24B | $0.21B | 1.14 |
| 1987-09-30 | $0.20B | $0.18B | 1.14 |
| 1987-06-30 | $0.21B | $0.19B | 1.12 |
| 1987-03-31 | $0.19B | $0.17B | 1.14 |
| 1986-12-31 | $0.20B | $0.17B | 1.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.338B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| ICON (ICLR) | Ireland | $12.935B | 17.58 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |